Abstract:A new leukaemia model has been established in mice by deleting the Pten tumour suppressor gene in fetal liver haematopoietic stem cells. The mice develop a myeloproliferative disorder that can lead to acute T lymphoblastic leukaemia. Progression of the condition is driven by leukaemia stem cells that require beta-catenin and incorporate a translocation that leads to overexpression of the c-myc oncogene, similar to findings in human acute T lymphoblastic leukaemia. The study illustrates how multiple genetic alterations can dictate hyperproliferative disorders and the progression to cancer. The loss of the Pten tumour suppressor in haematopoietic stem cells can lead to acute T lymphoblastic leukemia. This study illustrates how multi-genetic alterations can dictate hyperproliferative disorders and the progression to cancer. Cancer stem cells, which share many common properties and regulatory machineries with normal stem cells, have recently been proposed to be responsible for tumorigenesis and to contribute to cancer resistance1. The main challenges in cancer biology are to identify cancer stem cells and to define the molecular events required for transforming normal cells to cancer stem cells. Here we show that Pten deletion in mouse haematopoietic stem cells leads to a myeloproliferative disorder, followed by acute T-lymphoblastic leukaemia (T-ALL). Self-renewable leukaemia stem cells (LSCs) are enriched in the c-KitmidCD3+Lin- compartment, where unphosphorylated β-catenin is significantly increased. Conditional ablation of one allele of the β-catenin gene substantially decreases the incidence and delays the occurrence of T-ALL caused by Pten loss, indicating that activation of the β-catenin pathway may contribute to the formation or expansion of the LSC population. Moreover, a recurring chromosomal translocation, T(14;15), results in aberrant overexpression of the c-myc oncogene in c-KitmidCD3+Lin- LSCs and CD3+ leukaemic blasts, recapitulating a subset of human T-ALL. No alterations in Notch1 signalling are detected in this model, suggesting that Pten inactivation and c-myc overexpression may substitute functionally for Notch1 abnormalities2,3, leading to T-ALL development. Our study indicates that multiple genetic or molecular alterations contribute cooperatively to LSC transformation.

T-ALL Leukemia Stem Cell 'stemness' is Epigenetically Controlled by the Master Regulator SPI1

Chemoresistant Leukemia-Initiating Cell Expansion is Inhibited by Targeting Oncogenic Self-Renewal

A Regulatory Loop Involving Notch and Wnt Signaling Maintains Leukemia Stem Cells in T-Cell Acute Lymphoblastic Leukemia

PD-1 Signalling Defines and Protects Leukaemic Stem Cells from T Cell Receptor-Induced Cell Death in T Cell Acute Lymphoblastic Leukaemia

Suppression of Leukemia Development Caused by Pten Loss

The Non-Cell-autonomous Function of ID1 Promotes AML Progression Via ANGPTL7 from the Microenvironment.

Multi-genetic Events Collaboratively Contribute to Pten -Null Leukaemia Stem-Cell Formation

Transposable Elements Shape Stemness in Normal and Leukemic Hematopoiesis

Sphingosine-1 phosphate receptor 1 (S1PR1) expression maintains stemness of acute myeloid leukemia stem cells

Epigenetic dysregulation of ZEB1 is involved in LMO2-promoted T-cell acute lymphoblastic leukaemia leukaemogenesis.

Super-enhancer Landscape Reveals Leukemia Stem Cell Reliance on X-box Binding Protein 1 As a Therapeutic Vulnerability.

TET2-mediated mRNA demethylation regulates leukemia stem cell homing and self-renewal

Regulatory T cells promote the stemness of leukemia stem cells through IL10 cytokine-related signaling pathway

Targeted silencing of SOCS1 by DNMT1 promotes stemness of human liver cancer stem-like cells

Identification of a cancer stem-like population in the Lewis lung cancer cell line.

Sp1 and c-Myc modulate drug resistance of leukemia stem cells by regulating survivin expression through the ERK-MSK MAPK signaling pathway

Hematopoietic and Leukemic Stem Cells Have Distinct Dependence on Tcf1 and Lef1 Transcription Factors

Single-cell sequencing technology to characterize stem T-cell subpopulations in acute T-lymphoblastic leukemia and the role of stem T-cells in the disease process

Machine Learning and Integrative Analysis Reveals Stemness Index-associated Signature in Acute Myeloid Leukemia

Lysine-specific Demethylase 1 Promotes the Stemness and Chemoresistance of Lgr5+ Liver Cancer Initiating Cells by Suppressing Negative Regulators of Β-Catenin Signaling

Molecular Mechanisms for Stemness Maintenance of Acute Myeloid Leukemia Stem Cells